Landscape Capital Management’s Avidity Biosciences RNAM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-32,493
Closed -$2.34M 942
2025
Q4
$2.34M Buy
+32,493
New +$2.1M 0.16% 197
2024
Q4
Sell
-5,767
Closed -$265K 882
2024
Q3
$265K Buy
+5,767
New +$250K 0.03% 524
2023
Q1
Sell
-9,047
Closed -$201K 759
2022
Q4
$201K Buy
+9,047
New +$135K 0.03% 540

Other funds holding RNAM

Landscape Capital Management's RNAM Position: Q1 2026 in Review

Landscape Capital Management sold out of Avidity Biosciences (RNAM) in Q1 2026, closing a stake of 32,493 shares — an estimated $2.34M sold.

Landscape Capital Management first reported a position in RNAM in Q4 2022 and held it in 3 quarters. The position peaked at $2.34M in Q4 2025. 1 fund tracked by Wall St. Rank holds RNAM as of Q1 2026.

  • Landscape Capital Management reported no remaining Avidity Biosciences position as of Q1 2026 after selling out during the quarter.
  • Landscape Capital Management sold 32,493 Avidity Biosciences shares in Q1 2026, an estimated $2.34M.
  • Landscape Capital Management first reported a position in Avidity Biosciences in Q4 2022 and held it in 3 quarters.
  • Landscape Capital Management's Avidity Biosciences position peaked at $2.34M in Q4 2025.
  • 1 fund tracked by Wall St. Rank held Avidity Biosciences as of Q1 2026.

Based on Landscape Capital Management's 13F filing for Q1 2026, filed 12 May 2026.